Skip to main content

Published locations for FDA OKs Subcutaneous Vedolizumab for Crohn’s Maintenance Therapy

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA OKs Subcutaneous Vedolizumab for Crohn’s Maintenance Therapy

User login

  • Reset your password
  • /content/fda-oks-subcutaneous-vedolizumab-crohns-maintenance-therapy
  • /familypracticenews/article/268867/ibd-intestinal-disorders/fda-oks-subcutaneous-vedolizumab-crohns
  • /gihepnews/article/268867/ibd-intestinal-disorders/fda-oks-subcutaneous-vedolizumab-crohns
  • /internalmedicinenews/article/268867/ibd-intestinal-disorders/fda-oks-subcutaneous-vedolizumab-crohns
  • /internalmedicine/article/268867/ibd-intestinal-disorders/fda-oks-subcutaneous-vedolizumab-crohns
  • /familymedicine/article/268867/ibd-intestinal-disorders/fda-oks-subcutaneous-vedolizumab-crohns